Form 4 holding
Director
Savara Inc
- Security class
- Common Stock
- Shares / value
- 22,500
- Estimated value
- $100,125
- Report date
- 14 Dec 2023
- Price
- $4.45
- Ownership
- Direct
Ricky Sun
Insider Reports History
- Reporting-owner location
- Boston, MA
- Latest reporting-owner signature
- /s/ Ricky Sun
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Ricky Sun
Form 4 holding
Director
Savara Inc
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 40,000
- Estimated value
- Report date
- 13 Dec 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Arcutis Biotherapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 13,391
- Estimated value
- Report date
- 09 Jun 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Annexon, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 10,000
- Estimated value
- Report date
- 02 Jun 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Ricky Sun
4
SVRA
Savara Inc
- Report period
- 14 Dec 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Dec 2023, 18:10
- Role
- Director
- Next action
- Open filing details
4
SVRA
Savara Inc
- Report period
- 13 Dec 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Dec 2022, 15:13
- Role
- Director
- Next action
- Open filing details
4
SVRA
Savara Inc
- Report period
- 14 Dec 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Dec 2021, 17:30
- Role
- Director
- Next action
- Open filing details
4
ARQT
Arcutis Biotherapeutics, Inc.
- Report period
- 09 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 11 Jun 2021, 17:30
- Role
- Director
- Next action
- Open filing details
4
ANNX
Annexon, Inc.
- Report period
- 02 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 04 Jun 2021, 17:00
- Role
- Director
- Next action
- Open filing details